Skip to main content
JHX
NYSE Manufacturing

James Hardie Exceeds FY26 Adjusted EBITDA Guidance, Projects Strong FY27 Growth & Free Cash Flow

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
8
Price
$18.9
Mkt Cap
$10.86B
52W Low
$16.46
52W High
$29.825
Market data snapshot near publication time

summarizeSummary

James Hardie Industries exceeded its Adjusted EBITDA guidance for Q4 and full-year FY26 and provided an optimistic FY27 outlook with projected Adjusted EBITDA growth and increased Free Cash Flow, driven by synergy realization.


check_boxKey Events

  • Exceeded FY26 Adjusted EBITDA Guidance

    The company reported Q4 FY26 Adjusted EBITDA of $381 million and full-year FY26 Adjusted EBITDA of $1.27 billion, both exceeding prior guidance and expectations.

  • Strong FY27 Outlook

    James Hardie is targeting Pro Forma Adjusted EBITDA growth of 4% to 8% in FY27 and expects Free Cash Flow to exceed $500 million, an increase of over $200 million year-over-year.

  • AZEK Acquisition Synergies Ahead of Schedule

    Cost synergies from the AZEK acquisition are ahead of schedule, and commercial synergies are on track, reinforcing confidence in long-term value creation from the integration.

  • Significant Net Sales Growth

    Net Sales increased 45% year-over-year in Q4 FY26 to $1.40 billion and 25% for the full year to $4.84 billion, primarily driven by the AZEK acquisition.


auto_awesomeAnalysis

James Hardie reported strong adjusted financial results for Q4 and full-year FY26, surpassing its Adjusted EBITDA guidance. The company also provided a positive outlook for FY27, projecting significant growth in Adjusted EBITDA and a substantial increase in Free Cash Flow, driven by successful integration and synergy realization from the AZEK acquisition. While GAAP net income declined due to acquisition-related expenses, the focus on adjusted metrics and future cash generation indicates a solid operational performance in a challenging market.

At the time of this filing, JHX was trading at $18.90 on NYSE in the Manufacturing sector, with a market capitalization of approximately $10.9B. The 52-week trading range was $16.46 to $29.83. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed JHX - Latest Insights

JHX
May 19, 2026, 9:38 PM EDT
Source: Reuters
Importance Score:
8
JHX
May 19, 2026, 4:41 PM EDT
Source: Reuters
Importance Score:
8
JHX
May 19, 2026, 4:36 PM EDT
Filing Type: 10-K
Importance Score:
8
JHX
May 19, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
8
JHX
May 19, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
JHX
Mar 13, 2026, 1:56 PM EDT
Filing Type: 6-K
Importance Score:
7
JHX
Feb 10, 2026, 6:06 PM EST
Filing Type: 6-K
Importance Score:
8
JHX
Jan 15, 2026, 4:44 PM EST
Filing Type: 6-K
Importance Score:
7